Company research
CHINOOK THERAPEUTICS, INC.
CIK 1435049Updated Nov 16, 2026
Securities
Historical securities (1)
KDNY · NASDAQ · equity · closed Aug 11, 2023Name history
ADURO BIOTECH, INC. · through Oct 15, 2020ADURO BIOTECH · through Apr 22, 2011
KDNY price & chart
Historical security
This listing closed Aug 11, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 574,084,000Source | 563,803,000Source | 429,002,000Source | 291,313,000Source |
| Property, Plant and Equipment, NetUSD | 16,908,000Source | 18,935,000Source | 20,626,000Source | 24,688,000Source |
| GoodwillUSD | 117,000Source | 117,000Source | 22,441,000Source | 8,167,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 60,837,000Source | 62,559,000Source | 66,991,000Source | 18,978,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 115,438,000Source | 181,724,000Source | 187,750,000Source | 59,624,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 262,000Source | 342,000Source |
| Assets, CurrentUSD | 385,592,000Source | 300,639,000Source | 254,081,000Source | 217,902,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 6,176,000Source | 3,741,000Source | 6,447,000Source | 3,958,000Source |
| Operating Lease, Right-of-Use AssetUSD | 48,970,000Source | 55,385,000Source | 55,673,000Source | 21,110,000Source |
| Other Assets, NoncurrentUSD | 7,326,000Source | 6,474,000Source | 4,440,000Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 132,143,000Source | 110,160,000Source | 94,380,000Source | 225,718,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 7,000Source | 5,000Source | 4,000Source | 8,000Source |
| Retained Earnings (Accumulated Deficit)USD | -419,631,000Source | -231,766,000Source | -128,829,000Source | -486,904,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -3,164,000Source | -55,000Source | 11,000Source | 414,000Source |
| Stockholders' Equity Attributable to ParentUSD | 441,941,000Source | 453,643,000Source | 334,622,000Source | 65,595,000Source |
| Additional Paid in Capital, Common StockUSD | 864,729,000Source | 685,459,000Source | 463,436,000Source | 552,077,000Source |
| Liabilities and EquityUSD | 574,084,000Source | 563,803,000Source | 429,002,000Source | 291,313,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 50,835,000Source | 40,085,000Source | 22,809,000Source | 21,601,000Source |
| Operating Lease, Liability, CurrentUSD | 4,948,000Source | 4,401,000Source | 3,045,000Source | 1,803,000Source |
| Accounts Payable, CurrentUSD | 9,751,000Source | 8,580,000Source | 3,995,000Source | 414,000Source |
| Operating Lease, Liability, NoncurrentUSD | 34,494,000Source | 39,589,000Source | 38,709,000Source | 31,636,000Source |
| Deferred Income Tax Liabilities, NetUSD | 5,076,000Source | 735,000Source | 16,377,000Source | — |
| Other Liabilities, NoncurrentUSD | — | — | 905,000Source | 940,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 5,076,000Source | 735,000Source | 16,380,000Source | 3,527,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -187,865,000Source | -102,937,000Source | -81,622,000Source | -82,372,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -8,970,000Source | 9,799,000Source | -818,000Source | -11,695,000Source |
| Increase (Decrease) in Accounts PayableUSD | 1,380,000Source | 4,547,000Source | 553,000Source | -799,000Source |
| Deferred Income Tax Expense (Benefit)USD | -4,341,000Source | -2,093,000Source | -2,003,000Source | -2,412,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -117,481,000Source | -102,744,000Source | -55,848,000Source | -65,508,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -99,993,000Source | -112,639,000Source | 109,672,000Source | -1,763,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,653,000Source | 1,878,000Source | 797,000Source | 1,260,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 151,432,000Source | 209,524,000Source | 124,292,000Source | 743,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -66,286,000Source | -5,702,000Source | 178,143,000Source | -66,686,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 117,512,000Source | 183,798,000Source | 189,500,000Source | 60,092,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -244,000Source | 157,000Source | 27,000Source | -158,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 20,054,000Source | 12,785,000Source | 3,611,000Source | 12,439,000Source |
| Amortization of Intangible AssetsUSD | 1,722,000Source | 1,687,000Source | 422,000Source | 554,000Source |
| DepreciationUSD | — | — | — | 4,300,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | 7,227,000Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -256,000Source | — | 44,000Source | -6,000Source |
| General and Administrative ExpenseUSD | 36,291,000Source | 31,899,000Source | 19,071,000Source | 34,795,000Source |
| GoodwillUSD | 117,000Source | 117,000Source | 22,441,000Source | 8,167,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 5,006,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -3,250,000Source | -1,636,000Source | — | — |
| Income Tax Expense (Benefit)USD | 4,341,000Source | 2,093,000Source | -2,003,000Source | -2,412,000Source |
| Investment Income, InterestUSD | — | — | — | 5,451,000Source |
| Net Income (Loss) Attributable to ParentUSD | -187,865,000Source | -102,937,000Source | -81,622,000Source | -82,372,000Source |
| Operating ExpensesUSD | — | — | 57,054,000Source | 107,400,000Source |
| Operating Lease, ExpenseUSD | 6,279,000Source | 5,688,000Source | 1,486,000Source | — |
| Other Nonoperating Income (Expense)USD | — | -170,000Source | 313,000Source | -93,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 362,000Source | 530,000Source |
| Realized Investment Gains (Losses)USD | — | — | — | 4,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 6,128,000Source | 51,625,000Source | 827,000Source | 17,258,000Source |
| Operating Income (Loss)USD | -185,083,000Source | -99,038,000Source | -56,227,000Source | -90,142,000Source |
| Other Nonoperating Income (Expense)USD | — | -170,000Source | 313,000Source | -93,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -183,524,000Source | -100,844,000Source | -83,625,000Source | -84,784,000Source |
| Income Tax Expense (Benefit)USD | 4,341,000Source | 2,093,000Source | -2,003,000Source | -2,412,000Source |
| Net Income (Loss) Attributable to ParentUSD | -187,865,000Source | -102,937,000Source | -81,622,000Source | -82,372,000Source |
| Earnings Per Share, BasicUSD per share | -2.92Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -2.92Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 64,370,000Source | 45,755,000Source | 13,463,477Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 64,370,000Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,722,000Source | 1,687,000Source | 422,000Source | 554,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 3,400,000Source | 3,100,000Source | 1,100,000Source | — |
| General and Administrative ExpenseUSD | 36,291,000Source | 31,899,000Source | 19,071,000Source | 34,795,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -152,508,000Source | -59,702,000Source | -68,636,000Source | -61,292,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -3,250,000Source | -1,636,000Source | — | — |
| Investment Income, InterestUSD | — | — | — | 5,451,000Source |
| Investment Income, NetUSD | 4,809,000Source | — | — | — |
| Operating ExpensesUSD | — | — | 57,054,000Source | 107,400,000Source |
| Operating Lease, ExpenseUSD | 6,279,000Source | 5,688,000Source | 1,486,000Source | — |
| Realized Investment Gains (Losses)USD | — | — | — | 4,000Source |
| Research and Development ExpenseUSD | 141,211,000Source | 96,987,000Source | 36,051,000Source | 67,045,000Source |